Nuage-therapeutics

New selective and potent drugs for intrinsically disordered targets

Our science

Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.

Our team

Xavier Salvatella

Xavier Salvatella

Founder

Mateusz Biesaga

Mateusz Biesaga

Founder

Denes Hnisz

Denes Hnisz

Founder

Georgina Sorrosal

Georgina Sorrosal

Head of Operations

Jordina Guillén

Jordina Guillén

Head of Research

Board of Directors

Clara Campàs

Clara Campàs

Board member

Xavier Salvatella

Xavier Salvatella

Board member

Denes Hnisz

Denes Hnisz

Board member

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA is launched with the support of Asabys.

Private investors:

Project grants:

Get in touch

Address:
Parc Científic de Barcelona 
c/ Baldiri Reixac 4-8 (Torre R)
08028 Barcelona

5 + 3 =